慢性丙型肝炎患者中的隐匿性乙型肝炎病毒感染：幕后黑手还是旁观者？ - Suppr | 超能文献

Occult hepatitis B virus infection in patients with chronic hepatitis C: An actor behind the scene or just a bystander?

作者信息

Chu Chi-Jen, Lee Shou-Dong

出版信息

J Gastroenterol Hepatol. 2010 Feb;25(2):221-3. doi: 10.1111/j.1440-1746.2009.06134.x.

DOI:10.1111/j.1440-1746.2009.06134.x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Occult hepatitis B virus infection in patients with chronic hepatitis C: An actor behind the scene or just a bystander?慢性丙型肝炎患者中的隐匿性乙型肝炎病毒感染：幕后黑手还是旁观者？

J Gastroenterol Hepatol. 2010 Feb;25(2):221-3. doi: 10.1111/j.1440-1746.2009.06134.x.

2

Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.聚乙二醇干扰素联合利巴韦林治疗慢性丙型肝炎合并隐匿性乙型肝炎病毒双重感染患者的疗效。

J Gastroenterol Hepatol. 2010 Feb;25(2):259-63. doi: 10.1111/j.1440-1746.2009.06006.x. Epub 2009 Oct 9.

3

Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.隐匿性乙肝病毒感染与慢性丙型肝炎联合治疗早期丙型肝炎病毒复制的抑制

J Biol Regul Homeost Agents. 2003 Apr-Jun;17(2):172-5.

4

Impact of occult hepatitis B virus infection or hepatitis B virus DNA integration on efficacy of chronic hepatitis C treatment with peginterferon and ribavirin: where are we?隐匿性乙型肝炎病毒感染或乙型肝炎病毒DNA整合对聚乙二醇干扰素和利巴韦林治疗慢性丙型肝炎疗效的影响：我们目前的进展如何？

J Clin Gastroenterol. 2014 Jan;48(1):3-5. doi: 10.1097/MCG.0b013e3182a6633d.

5

Can Peg-IFN alpha-2a plus ribavirin be used to treat patients with chronic hepatitis C and normal alanine aminotransferase levels?聚乙二醇干扰素α-2a联合利巴韦林可用于治疗丙型肝炎且丙氨酸转氨酶水平正常的患者吗？

Nat Clin Pract Gastroenterol Hepatol. 2005 Mar;2(3):130-1. doi: 10.1038/ncpgasthep0117.

6

Drug induced hypersensitivity syndrome by triple therapy of peginterferon alpha2b, ribavirin and telaprevir in patient with double positive for HBV and HCV.聚乙二醇干扰素α2b、利巴韦林和特拉匹韦三联疗法诱发的药物超敏反应综合征，见于乙肝和丙肝双阳性患者。

Hepatogastroenterology. 2013 Oct;60(127):1557-60.

7

Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.慢性丙型肝炎对慢性乙型肝炎携带者的联合治疗反应不佳。

Neth J Med. 2008 May;66(5):191-5.

8

Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C.隐匿性乙型肝炎病毒感染不影响丙型肝炎慢性感染静脉吸毒者的肝脏组织学或对α干扰素和利巴韦林治疗的反应。

J Clin Virol. 2004 Mar;29(3):160-6. doi: 10.1016/S1386-6532(03)00117-3.

9

Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection.慢性乙型和丙型肝炎病毒合并感染时血浆、外周血单个核细胞及肝组织中的病毒学模式与临床结局

Antivir Ther. 2008;13(2):307-18.

10

Recurrence of hepatitis C virus infection during pityriasis rosea.玫瑰糠疹期间丙型肝炎病毒感染复发。

Acta Derm Venereol. 2013 Jul 6;93(4):483. doi: 10.2340/00015555-1509.

引用本文的文献

1

Occult Hepatitis B in Hemodialysis Patients is a Debate.血液透析患者中的隐匿性乙型肝炎是一个有争议的问题。

Adv Biomed Res. 2018 Jun 25;7:104. doi: 10.4103/abr.abr_233_16. eCollection 2018.

2

Isolated anti-hbc and occult HBV infection in dialysis patients.透析患者中的孤立性抗-HBc及隐匿性HBV感染

Nephrourol Mon. 2014 Nov 30;7(1):e22674. doi: 10.5812/numonthly.22674. eCollection 2015 Jan.

3

Clinical significance of occult hepatitis B virus infection.隐匿性乙型肝炎病毒感染的临床意义。

World J Gastroenterol. 2011 Mar 28;17(12):1549-52. doi: 10.3748/wjg.v17.i12.1549.